Literature DB >> 20360425

Ciliary beat frequency controlled by oestradiol and progesterone during ovarian cycle in guinea-pig Fallopian tube.

Ayumi Nishimura1, Ko Sakuma, Chikao Shimamoto, Shigenori Ito, Takashi Nakano, Eriko Daikoku, Masahide Ohmichi, Takahisa Ushiroyama, Minoru Ueki, Hiroko Kuwabara, Hiroshi Mori, Takashi Nakahari.   

Abstract

The ciliary beat frequency (CBF) of guinea-pig fimbria during the ovarian cycle was measured by video microscopy using a high-speed camera (500 Hz). In the follicular phase, with increasing concentrations of beta-oestradiol ([betaE(2)]) and a low concentration of progesterone ([PRG]), CBF increased from 13.5 to 16 Hz. In the ovulatory phase, with further increase of [betaE(2)], CBF decreased gradually from 16 to 13.5 Hz. In the early luteal phase, with low [PRG] and [betaE(2)], CBF increased to 17 Hz; however, in the middle luteal phase, with increasing [PRG], CBF decreased (12 Hz), and in the late luteal phase, with decreasing [PRG], CBF increased to 15 Hz. Then, in the resting phase, with low [betaE(2)] and [PRG], CBF decreased immediately to 14 Hz. The CBF of the fimbria was measured in guinea-pigs treated with beta-oestradiol benzoate (betaE(2)B) or medroxyprogesterone (mPRG). A low dose of betaE(2)B increased CBF to 14.5 Hz, whereas a high dose decreased it to 11 Hz. A betaE(2) receptor blocker, ICI-182,780, abolished the betaE(2)B-induced CBF changes and maintained CBF at 12.0 Hz. Medroxyprogesterone decreased CBF to 12.5 Hz, and mifepristone (a PRG receptor blocker) abolished the mPRG-induced CBF decrease and maintained CBF at 15 Hz. The addition of both blockers increased CBF to 18 Hz, suggesting that activation of betaE(2) or PRG receptors decreases the CBF of the fimbria. In conclusion, a moderate [betaE(2)] increase maintains a high CBF (15.5 Hz) in the follicular phase, and then further [betaE(2)] increase decreases CBF to 13.5 Hz in the ovulatory phase. In the early and late luteal phase, low [betaE(2)] and [PRG] increase CBF to 17 and 15 Hz, respectively, and in the middle luteal phase a high [PRG] decreases CBF (to 12 Hz). Thus, the CBF of the fimbria was controlled by signals via betaE(2) and PRG receptors in guinea-pigs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20360425     DOI: 10.1113/expphysiol.2010.052555

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  7 in total

1.  Estrogen receptor α is required for oviductal transport of embryos.

Authors:  Shuai Li; Sofia R S O'Neill; Yong Zhang; Michael J Holtzman; Ken-Ichi Takemaru; Kenneth S Korach; Wipawee Winuthayanon
Journal:  FASEB J       Date:  2017-01-12       Impact factor: 5.191

Review 2.  Tubal transport of gametes and embryos: a review of physiology and pathophysiology.

Authors:  Mohammad Ezzati; Ovrang Djahanbakhch; Sara Arian; Bruce R Carr
Journal:  J Assist Reprod Genet       Date:  2014-08-13       Impact factor: 3.412

3.  The role of estrogen in the pathophysiology of tubal ectopic pregnancy.

Authors:  Ruijin Shao; Yi Feng; Shien Zou; Birgitta Weijdegård; Gencheng Wu; Mats Brännström; Håkan Billig
Journal:  Am J Transl Res       Date:  2012-07-20       Impact factor: 4.060

Review 4.  Physiological Action of Progesterone in the Nonhuman Primate Oviduct.

Authors:  Ov D Slayden; Fangzhou Luo; Cecily V Bishop
Journal:  Cells       Date:  2022-05-03       Impact factor: 7.666

Review 5.  Laboratory models for studying ectopic pregnancy.

Authors:  Jeremy K Brown; Andrew W Horne
Journal:  Curr Opin Obstet Gynecol       Date:  2011-08       Impact factor: 1.927

6.  Can the antral follicular count modulate the gene expression of bovine oviducts in Aberdeen Angus and Nelore heifers?

Authors:  Patricia Kubo Fontes; Ronaldo Luis Ereno; André Rebello Peixoto; Robson Francisco Carvalho; Wellerson Rodrigo Scarano; Luzia Aparecida Trinca; Ciro Moraes Barros; Anthony César de Souza Castilho
Journal:  PLoS One       Date:  2018-08-29       Impact factor: 3.240

Review 7.  Progesterone and Inflammatory Response in the Oviduct during Physiological and Pathological Conditions.

Authors:  Emily A McGlade; Akio Miyamoto; Wipawee Winuthayanon
Journal:  Cells       Date:  2022-03-23       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.